Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Trevi Therapeutics Inc (TRVI)

   0 (0%) 12-31 19:00
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.913 - 3.941 3.941 - 3.962
Low: 3.709 - 3.738 3.738 - 3.76
Close: 3.802 - 3.847 3.847 - 3.882

Technical analysis

as of: 2020-09-25 4:35:36 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.10     One year: 5.89
Support: Support1: 3.28    Support2: 2.73
Resistance: Resistance1: 4.37    Resistance2: 5.04
Pivot: 3.78
Moving Average: MA(5): 3.88     MA(20): 3.78
MA(100): 4.44     MA(250): 4.13
MACD: MACD(12,26): -0.17     Signal(9): -0.23
Stochastic oscillator: %K(14,3): 75.59     %D(3): 75.76
RSI: RSI(14): 45.42
52-week: High: 8.50  Low: 1.33  Change(%): -14.7
Average Vol(K): 3-Month: 10383  10-Days: 3647

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
TRVI has closed below upper band by 38.9%. Bollinger Bands are 72% narrower than normal. The narrow width of the bands suggests low volatility as compared to TRVI's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 25 Sep 2020
Short Interest On Trevi Therapeutics, Inc. (TRVI) Might Be Rising - Invest Million

Wed, 09 Sep 2020
Trevi Therapeutics to Present at H.C. Wainwright Global Investment Conference - GlobeNewswire

Thu, 13 Aug 2020
Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Mon, 13 Jul 2020
Trevi Therapeutics Announces Positive Outcome of the Sample Size Re-Estimation Analysis in PRISM Trial for Severe Pruritus in Patients With Prurigo Nodularis - GlobeNewswire

Fri, 29 May 2020
Trevi Therapeutics to Hold Virtual 2020 Annual Meeting of Stockholders - GlobeNewswire

Thu, 07 May 2020
Trevi Therapeutics Announces First Quarter 2020 Financial Results and Corporate Update - GlobeNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. (M) 18
Shares Float (M) 4
% Held by Insiders 7.49
% Held by Institutions 95.05
Shares Short (K) 28
Shares Short P. Month (K) 50

Stock Financials

EPS -1.664
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.240
Profit Margin
Operating Margin
Return on Assets (ttm) -31.2
Return on Equity (ttm) -55.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.668
Qtrly Earnings Growth
Operating Cash Flow (M) -27
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -2.31
PEG Ratio
Price to Book value 1.71
Price to Sales
Price to Cash Flow -2.59

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.